v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net increase (decrease) in net assets resulting from operations $ 151,575 $ 437,288
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Net change in unrealized (appreciation) depreciation on investments 99,414 89,206
Net change in unrealized (appreciation) depreciation on derivative instruments (1,906) 1,541
Net change in unrealized (appreciation) depreciation on translation of assets and liabilities in foreign currencies 946 (1,125)
Net realized (gain) loss on investments 275,192 1,977
Net change due to hedging activity 787 (814)
Net realized (gain) loss on foreign currency transactions (12,359) 13,085
Net accretion of discount and amortization of premium (36,883) (41,004)
Payment-in-kind interest capitalized (61,434) (73,386)
Amortization of deferred financing costs 4,858 4,204
Amortization of original issue discount and debt issuance costs (including premiums and discounts) 13,327 11,029
Purchases of investments (884,993) (2,227,166)
Proceeds from sale of investments and principal repayments 1,856,503 1,600,101
Changes in operating assets and liabilities:    
Interest receivable 3,496 6,846
Receivable for investments (10,533) (14,271)
Derivative instruments, net (99,892) (13,193)
Receivable from broker 1,053 (6,368)
Payable for investments (1,912) (13,614)
Due to affiliates (237) (2,353)
Management fees payable (2,353) 2,654
Income based incentive fees payable (9,565) (7,454)
Capital gains based incentive fees payable 0 0
Interest payable 5,306 4,409
Accrued expenses and other liabilities (821) (585)
Net cash provided by (used in) operating activities 1,289,569 (228,993)
Cash flows from financing activities:    
Borrowings on debt 2,730,858 1,727,066
Repayments on debt (3,644,323) (1,228,031)
Deferred financing costs paid (6,376) (3,558)
Debt issuance costs paid (2,925) (2,402)
Dividends paid in cash (512,399) (507,195)
Proceeds from issuance of Common Shares, net of offering and underwriting costs 0 274,453
Net cash provided by (used in) financing activities (1,435,165) 260,333
Net increase (decrease) in cash and cash equivalents (145,596) 31,340
Effect of foreign exchange rate changes on cash and cash equivalents (1,480) (11,055)
Cash and cash equivalents (including restricted cash), beginning of period 289,605 229,606
Cash and cash equivalents (including restricted cash), end of period 142,529 249,891
Supplemental information and non-cash activities:    
Interest paid during the period 294,681 278,653
Distribution payable 179,387 177,837
Reinvestment of distributions during the period 24,215 15,984
Accrued but unpaid debt issuance costs 844 250
Excise and other taxes paid $ 16,026 $ 15,076